0001179110-12-005193.txt : 20120316 0001179110-12-005193.hdr.sgml : 20120316 20120316141529 ACCESSION NUMBER: 0001179110-12-005193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120314 FILED AS OF DATE: 20120316 DATE AS OF CHANGE: 20120316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISARO PAUL CENTRAL INDEX KEY: 0001237253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 12697065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0304 4 2012-03-14 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001237253 BISARO PAUL MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 1 1 0 0 President & CEO Common Stock, par value $0.0033 2012-03-14 4 F 0 6521 59.21 D 307339 D Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. Paul M. Bisaro 2012-03-16